Business Description
Immuron Ltd
ISIN : AU000000IMC7
Description
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 66.99 | |||||
| Equity-to-Asset | 0.82 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -3.73 | |||||
| Beneish M-Score | -0.69 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 180.2 | |||||
| 3-Year EBITDA Growth Rate | 7.6 | |||||
| 3-Year EPS without NRI Growth Rate | 8 | |||||
| 3-Year FCF Growth Rate | -13 | |||||
| 3-Year Book Growth Rate | -21.1 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 13.39 | |||||
| 9-Day RSI | 18.29 | |||||
| 14-Day RSI | 22.61 | |||||
| 6-1 Month Momentum % | 1.82 | |||||
| 12-1 Month Momentum % | 31.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.46 | |||||
| Quick Ratio | 4.87 | |||||
| Cash Ratio | 4.32 | |||||
| Days Inventory | 314.07 | |||||
| Days Sales Outstanding | 23.47 | |||||
| Days Payable | 241.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | 0.1 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 68.04 | |||||
| Operating Margin % | -106.36 | |||||
| Net Margin % | -141.49 | |||||
| FCF Margin % | -120.02 | |||||
| ROE % | -41.74 | |||||
| ROA % | -36.24 | |||||
| ROIC % | -253.94 | |||||
| 3-Year ROIIC % | 2944.09 | |||||
| ROC (Joel Greenblatt) % | -3396.57 | |||||
| ROCE % | -41.34 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.57 | |||||
| PB Ratio | 1.34 | |||||
| Price-to-Tangible-Book | 1.13 | |||||
| EV-to-EBIT | -0.81 | |||||
| EV-to-EBITDA | -0.81 | |||||
| EV-to-Revenue | 1.15 | |||||
| EV-to-Forward-Revenue | 1.02 | |||||
| EV-to-FCF | -0.96 | |||||
| Price-to-Net-Current-Asset-Value | 1.5 | |||||
| Price-to-Net-Cash | 2.25 | |||||
| Earnings Yield (Greenblatt) % | -123.46 | |||||
| FCF Yield % | -34.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Immuron Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 3.017 | ||
| EPS (TTM) (€) | -0.019 | ||
| Beta | 1.23 | ||
| Volatility % | 70.58 | ||
| 14-Day RSI | 22.61 | ||
| 14-Day ATR (€) | 0.00064 | ||
| 20-Day SMA (€) | 0.04775 | ||
| 12-1 Month Momentum % | 31.76 | ||
| 52-Week Range (€) | 0.035 - 0.086 | ||
| Shares Outstanding (Mil) | 228 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Immuron Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Immuron Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Immuron Ltd Frequently Asked Questions
What is Immuron Ltd(STU:ANW)'s stock price today?
The current price of STU:ANW is €0.05. The 52 week high of STU:ANW is €0.09 and 52 week low is €0.04.
When is next earnings date of Immuron Ltd(STU:ANW)?
The next earnings date of Immuron Ltd(STU:ANW) is .
Does Immuron Ltd(STU:ANW) pay dividends? If so, how much?
Immuron Ltd(STU:ANW) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers